Hugh Carey is a Nephrology physician affiliated with Yale New Haven Hospital. OpenAlex indexes 12 publications with 355 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
136 Sherman Ave
Suite 405
New Haven, CT 065115238
Telephone
203-787-0117Registry record last updated 10 Apr 2013.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20254 payments
- Novo Nordisk IncProgram year20253 payments
- Mallinckrodt Hospital Products Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
60.6%Calcium channel blocker15.5%Amlodipine Besylate100%Part D≥44 patientsBeta blocker7.9%Carvedilol81%Nebivolol Hcl19%Part D<11 patients+ 9 more classes in this area
Other
15.8%Phosphate Binder8.5%Sevelamer Carbonate83%Renvela18%Part D<11 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia7.3%Lokelma100%Part D≥17 patientsMetabolism & gastrointestinal
14.1%SGLT2 inhibitor8.3%Farxiga73%Jardiance27%Part D<11 patientsMetabolic Alkalinizer2.5%Potassium Citrate Er100%Part D≥12 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1993–1995 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pauci-Immune Crescentic Glomerulonephritis Linked to Candida parapsilosis Fungemia
Journal of the American Society of Nephrology
2024 - Recurrent High Anion Gap Metabolic Acidosis Secondary to 5-Oxoproline (Pyroglutamic Acid)
American Journal of Kidney Diseases
2005 - Patients’ Descriptions of Specific Factors Leading to Modality Selection of Chronic Peritoneal Dialysis Or Hemodialysis
Peritoneal Dialysis International
2002 - Continuous peritoneal dialysis and the extended care facility
American Journal of Kidney Diseases
2001
Similar KOLs
Other experts from the same institution or the same specialty.
Gerard Sanacora, MD, PhD
Yale New Haven Hospital
John Elefteriades, MD
Yale New Haven Hospital
Jeptha Curtis, MD
Yale New Haven Hospital
Erica Spatz, MD
Yale New Haven Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”